AstraZeneca has agreed to settle two lawsuits in Texas accusing it of "off-label marketing" of rosuvastatin calcium (Crestor—AstraZeneca) and quetiapine fumarate (Seroquel—AstraZeneca) to Medicaid…
After two proxy-advisory firms recommended that shareholders back the proposed merger of Cigna and Express Scripts, billionaire activist investor Carl Icahn said Monday that he has dropped his plan…
New users of sodium-glucose cotransporter 2 (SGLT-2) inhibitors may have a greater risk of amputation compared with some oral treatments for type 2 diabetes, according to new research. The…
Of the millions of Americans who believe they are allergic to penicillin, experts estimate that 90% were wrongly diagnosed, were never diagnosed in the first place, or have grown out of an allergy…
Westminster Pharmaceuticals has announced a voluntary, nationwide recall of all lots of levothyroxine and liothyronine 15 mg, 30 mg, 60 mg, 90 mg, and 120 mg to the wholesale level. The recall is…
With palliative care specialists getting involved with terminally ill patients sooner, the role of opioids needs to be reexamined. Historically, they have played a significant role in keeping…
Some of the world's largest technology companies have pledged to remove barriers to the adoption of technologies for health care interoperability. Though the companies—including Alphabet, Amazon, IBM…
Although premiums have risen little since Medicare Part D was introduced, costs for taxpayers have skyrocketed 72% from 2007 to 2016. Much of this increase is due to growing enrollment and higher…
Emergent BioSolutions has entered into a definitive agreement to acquire PaxVax, an independent vaccine company. PaxVax is majority owned by an affiliate of Cerberus Capital Management, while…
In this interview, Janet Woodcock—director of FDA's Center for Drug Evaluation and Research (CDER)—discusses recent and upcoming changes including the reorganization of CDER's Office of New Drugs (…